ArticleJournal of asthma and allergy2022

Real-World Clinical Outcomes in Asthmatic Patients Switched from Omalizumab to Anti-Interleukin-5 Therapy.

Emily O'Reilly et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.